Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer

被引：9

作者：

Kumai, Tatsuo ^{[1
]}

Mizukoshi, Eishiro ^{[1
]}

Hashiba, Tomomi ^{[2
]}

Nakagawa, Hidetoshi ^{[2
]}

Kitahara, Masaaki ^{[2
]}

Miyashita, Tomoharu ^{[2
]}

Mochizuki, Takafumi ^{[2
]}

Goto, Shigenori ^{[3
]}

Kamigaki, Takashi ^{[3
]}

Takimoto, Rishu ^{[3
]}

Yamashita, Taro ^{[1
]}

Sakai, Yoshio ^{[1
]}

Yamashita, Tatsuya ^{[1
]}

Honda, Masao ^{[1
]}

Tomita, Katsuro ^{[2
]}

Kaneko, Shuichi ^{[1
]}

机构：

[1] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan

[2] Kanazawa Adv Med Ctr, Kanazawa, Ishikawa, Japan

[3] Juntendo Univ, Sch Med, Dept Next Generat Cell & Immune Therapy, Seta Clin Grp, Tokyo, Japan

来源：

CYTOTHERAPY | 2021年 / 23卷 / 02期

关键词：

adoptive immunotherapy; alpha beta T cell; flow cytometry; immune cell profiling; pancreatic cancer; PHASE-III; GEMCITABINE; THERAPY; SAFETY;

D O I：

10.1016/j.jcyt.2020.08.001

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Background aims: Immunotherapy is effective for many types of cancer, but its benefits in advanced pancreatic cancer, which has a poor prognosis, are not well established. In this study, the authors examined the effects of adoptive T-cell immunotherapy (ATI) on immune cell profiles and prognosis in patients with unresectable advanced pancreatic cancer. Methods: Seventy-seven patients with unresectable advanced pancreatic cancer were treated with six cycles of alpha beta T cells alone or in combination with chemotherapy or chemoradiation. Immune cell profiles in peripheral blood samples obtained before and after treatment were comprehensively evaluated by flow cytometry. Furthermore, associations between changes in immune cell frequencies and prognosis were determined. Results: ATI prolonged survival to 18.7 months compared with previous estimates of 6.2-11.1 months for patients treated with chemotherapy alone. ATI decreased CD3+CD4+CD8-T cell frequency in peripheral blood and increased CD3+CD4-CD8+T cell frequency. An increase in CD3+T cells and CD3+TCR gamma delta-T cells in peripheral blood after treatment was associated with a good prognosis. Conclusions: ATI altered the immune profile in peripheral blood, including CD3+CD4-CD8+T cells, and improved prognosis in pancreatic cancer. (C) 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.

引用

页码：137 / 145

页数：9

共 16 条

[11] The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].

Pourshams, Akram ;

Sepanlou, Sadaf G. ;

Ikuta, Kevin S. ;

Bisignano, Catherine ;

Safiri, Saeid ;

Roshandel, Gholamreza ;

Sharif, Mehdi ;

Khatibian, Morteza ;

Fitzmaurice, Christina ;

Nixon, Molly R. ;

Abbasi, Nooshin ;

Afarideh, Mohsen ;

Ahmadian, Elham ;

Akinyemiju, Tomi ;

Alahdab, Fares ;

Alam, Tahiya ;

Alipour, Vahid ;

Allen, Christine A. ;

Anber, Nahla Hamed ;

Ansari-Moghaddam, Alireza ;

Arabloo, Jalal ;

Badawi, Alaa ;

Bagherzadeh, Mojtaba ;

Belayneh, Yaschilal Muche ;

Biadgo, Belete ;

Bijani, Ali ;

Biondi, Antonio ;

Bjorge, Tone ;

Borzi, Antonio M. ;

Bosetti, Cristina ;

Briko, Andrey Nikolaevich ;

Briko, Nikolay Ivanovich ;

Carreras, Giulia ;

Carvalho, Felix ;

Choi, Jee-Young J. ;

Dinh-Toi Chu ;

Anh Kim Dang ;

Daryani, Ahmad ;

Davitoiu, Dragos Virgil ;

Demoz, Gebre Teklemariam ;

Desai, Rupak ;

Dey, Subhojit ;

Hoa Thi Do ;

Huyen Phuc Do ;

Eftekhari, Aziz ;

Esteghamati, Alireza ;

Farzadfar, Farshad ;

Fernandes, Eduarda ;

Filip, Irina ;

Fischer, Florian .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (12) :934-947

[12] An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma [J].

Tang, Yichen ;

Xu, Xuejun ;

Guo, Shixiang ;

Zhang, Chaobin ;

Tang, Yan ;

Tian, Yi ;

Ni, Bing ;

Lu, Binfeng ;

Wang, Huaizhi .

PLOS ONE, 2014, 9 (03)

[13] Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer [J].

Topalian, Suzanne L. ;

Hodi, F. Stephen ;

Brahmer, Julie R. ;

Gettinger, Scott N. ;

Smith, David C. ;

McDermott, David F. ;

Powderly, John D. ;

Carvajal, Richard D. ;

Sosman, Jeffrey A. ;

Atkins, Michael B. ;

Leming, Philip D. ;

Spigel, David R. ;

Antonia, Scott J. ;

Horn, Leora ;

Drake, Charles G. ;

Pardoll, Drew M. ;

Chen, Lieping ;

Sharfman, William H. ;

Anders, Robert A. ;

Taube, Janis M. ;

McMiller, Tracee L. ;

Xu, Haiying ;

Korman, Alan J. ;

Jure-Kunkel, Maria ;

Agrawal, Shruti ;

McDonald, Daniel ;

Kollia, Georgia D. ;

Gupta, Ashok ;

Wigginton, Jon M. ;

Sznol, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2443-2454

[14] Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study [J].

Ueno, Hideki ;

Ioka, Tatsuya ;

Ikeda, Masafumi ;

Ohkawa, Shinichi ;

Yanagimoto, Hiroaki ;

Boku, Narikazu ;

Fukutomi, Akira ;

Sugimori, Kazuya ;

Baba, Hideo ;

Yamao, Kenji ;

Shimamura, Tomotaka ;

Sho, Masayuki ;

Kitano, Masayuki ;

Cheng, Ann-Lii ;

Mizumoto, Kazuhiro ;

Chen, Jen-Shi ;

Furuse, Junji ;

Funakoshi, Akihiro ;

Hatori, Takashi ;

Yamaguchi, Taketo ;

Egawa, Shinichi ;

Sato, Atsushi ;

Ohashi, Yasuo ;

Okusaka, Takuji ;

Tanaka, Masao .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (13) :1640-+

[15] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine [J].

Von Hoff, Daniel D. ;

Ervin, Thomas ;

Arena, Francis P. ;

Chiorean, E. Gabriela ;

Infante, Jeffrey ;

Moore, Malcolm ;

Seay, Thomas ;

Tjulandin, Sergei A. ;

Ma, Wen Wee ;

Saleh, Mansoor N. ;

Harris, Marion ;

Reni, Michele ;

Dowden, Scot ;

Laheru, Daniel ;

Bahary, Nathan ;

Ramanathan, Ramesh K. ;

Tabernero, Josep ;

Hidalgo, Manuel ;

Goldstein, David ;

Van Cutsem, Eric ;

Wei, Xinyu ;

Iglesias, Jose ;

Renschler, Markus F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18) :1691-1703

[16]

Weir Genevieve M, 2011, Cancers (Basel), V3, P3114, DOI 10.3390/cancers3033114

← 1 2 →